OpenVSafe by OpenVAERS
Search V-safe

3YK-21485-46708

3 vaccinations 2 coded responses 15 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
968 / HI
Registered
2021-06-13
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-10
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-13
    Registered in v-safe
  3. 2021-06-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-06-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness, Nausea
    Adult check-in
  5. 2021-06-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-06-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-06-17
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-06-24
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  9. 2021-07-01
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  10. 2021-07-02
    Dose 2 — Pfizer-BioNTech
  11. 2021-07-16
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-07-24
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  13. 2021-07-30
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-08-06
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-08-13
    Survey response — day 42, dose 2
    MedDRA: Nausea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nauseous
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  16. 2021-10-01
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-12-31
    Survey response — 6 months, dose 2
    MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Fever
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-12-31
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  19. 2022-01-05
  20. 2022-01-12
  21. 2022-01-14
    Dose 3 — Pfizer-BioNTech
  22. 2022-04-18
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-06-10Pfizer-BioNTech
22021-07-02Pfizer-BioNTech No
32022-01-14Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-12-31 Unsuccessful

Free text

Release 9 — day 42, dose 2

2021-08-13

Symptoms: Nauseous

Release 10 — 6 months, dose 2

2021-12-31

Symptoms: Fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNausea ✓ · ✓
SDPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release